Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 763781, 8 pages
http://dx.doi.org/10.1155/2014/763781
Research Article

Elucidation of Underlying Mechanisms by Which Millettia macrophylla Benth Induces Its Estrogenic Activity

1Laboratory of Physiology, Department of Life and Earth Sciences, Higher Teachers’ Training College, University of Maroua, P.O. Box 55, Maroua, Cameroon
2Laboratory of Animal Physiology, Department of Animal Biology and Physiology, Faculty of Science, University of Yaounde I, P.O. Box 812, Yaounde, Cameroon
3MIMR-PHI Institute of Medical Research, Departments of Molecular and Translational Sciences, Monash University, 246 Clayton Road, Level 4, VIC 3168, Melbourne, Australia

Received 31 March 2014; Accepted 28 May 2014; Published 10 August 2014

Academic Editor: Fermin Sanchez de Medina

Copyright © 2014 Stéphane Zingue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. T. Baker, R. P. Borris, B. Carté et al., “Natural product drug discovery and development: new perspectives on international collaboration,” Journal of Natural Products, vol. 58, no. 9, pp. 1325–1357, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Raja, P. Gajalakshmi, and M. Mohamed Mahroop Raja, “Drugs from the natural bio sources for human disease,” International Journal of Pharmacology, vol. 6, no. 4, pp. 360–363, 2010. View at Google Scholar · View at Scopus
  3. World Health Organization, Traditional Medicine: Fact Sheet 134. 2003-05, World Health Organization, 2003.
  4. S. Hausmann-Muela, J. M. Ribera, and I. Nyamongo, “Health-seeking behaviour and the health system response,” DCPP Working Paper 14, 2003. View at Google Scholar
  5. E. Kiawi, R. Edwards, J. Shu, N. Unwin, R. Kamadjeu, and J. C. Mbanya, “Knowledge, attitudes, and behavior relating to diabetes and its main risk factors among urban residents in Cameroon: a qualitative survey,” Ethnicity and Disease, vol. 16, no. 2, pp. 503–509, 2006. View at Google Scholar · View at Scopus
  6. D. A. Focho, W. T. Ndam, and B. A. Fonge, “Medicinal plants of Aguambu-Bamumbu in the Lebialem highlands, Southwest Province of Cameroon,” African Journal of Pharmacy and Pharmacology, vol. 3, no. 1, pp. 1–13, 2009. View at Google Scholar · View at Scopus
  7. L. K. Nzowa, L. Barboni, R. B. Teponno et al., “Rheediinosides A and B, two antiproliferative and antioxidant triterpene saponins from Entada rheedii,” Phytochemistry, vol. 71, no. 2-3, pp. 254–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Kuete and T. Efferth, “Cameroonian medicinal plants: Pharmacology and derived natural products,” Frontiers in Pharmacology, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Kuete and T. Efferth, “Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 752–766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Njamen, M. A. Mvondo, S. Djiogue, G. J. M. K. Wanda, C. B. M. Nde, and G. Vollmer, “Phytotherapy and womens reproductive health: the cameroonian perspective,” Planta Medica, vol. 79, no. 7, pp. 600–611, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. M. Burkill, The useful plants of west tropical Africa, vol. 3, Royal Botanic Gardens, Kew, UK, 1st edition, 1985.
  12. G. J. M. K. Wanda, D. Njamen, E. Yankep et al., “Estrogenic properties of isoflavones derived from Millettia griffoniana,” Phytomedicine, vol. 13, no. 3, pp. 139–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. T. Banzouzi, A. Prost, M. Rajemiarimirabo, and P. Ongoka, “Traditional uses of African Millettia species (Fabaceae),” International Journal of Botany, vol. 4, no. 4, pp. 406–420, 2008. View at Publisher · View at Google Scholar
  14. D. Njamen, C. B. Magne Ndé, Z. Tanee Fomum, and G. Vollmer, “Effects of the extracts of some tropical medicinal plants on estrogen inducible yeast and Ishikawa screens, and on ovariectomized Wistar rats,” Pharmazie, vol. 63, no. 2, pp. 164–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. J. M. Ketcha Wanda, G. Kretzschmar, D. Njamen, M. Tagatsing Fotsing, E. Yankep, and G. Vollmer, “Modulation of some estrogen-responsive genes in the vena cava of ovariectomised Wistar rats by griffonianone C, an isoflavone derived from Millettia griffoniana Baill. (Fabaceae),” Fitoterapia, vol. 81, no. 8, pp. 1232–1238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. I. O. Lawal, N. E. Uzokwe, A. B. I. Igboanugo et al., “Ethno medicinal information on collation and identification of some medicinal plants in Research Institutes of South-west Nigeria,” African Journal of Pharmacy and Pharmacology, vol. 4, no. 1, pp. 001–007, 2010. View at Google Scholar · View at Scopus
  17. M. D. Wasserman, C. A. Chapman, K. Milton, J. F. Gogarten, D. J. Wittwer, and T. E. Ziegler, “Estrogenic plant consumption predicts red colobus monkey (Procolobus rufomitratus) hormonal state and behavior,” Hormones and Behavior, vol. 62, no. 5, pp. 553–562, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Zingue, D. Njamen, J. Tchoumtchoua et al., “Effects of Millettia macrophylla (Fabaceae) extracts on estrogen target organs of female wistar rat,” Journal of Pharmacological Sciences, vol. 123, no. 2, pp. 123–120, 2013. View at Google Scholar
  19. M. F. W. Festing, “Suitability of the rat for different investigations in,” in Inbred and Genetically Defined Strains of Laboratory Animals—part I, Mouse and Rat, P. L. Altman and D. D. Katz, Eds., pp. 237–238, Federation of American Societies for Experimental Biology, Bethesda, Md, USA, 1979. View at Google Scholar
  20. A. G. Gornall, C. J. Bardawill, and M. M. David, “Determination of serum proteins by means of the biuret reaction,” The Journal of Biological Chemistry, vol. 177, no. 2, pp. 751–766, 1949. View at Google Scholar · View at Scopus
  21. S. Zingue, D. Njamen, M. A. Mvondo, and C. B. Magne Nde, “Preventive effects of the methanol soluble fraction of Millettia macrophylla Benth (Fabaceae) on an osteoporosis-like model of ovariectomized Wistar rats,” Journal of Complementary and Integrative Medicine, vol. 11, no. 2, pp. 83–92, 2014. View at Publisher · View at Google Scholar
  22. S. Zingue, C. B. Magne Nde, and D. Njamen, “The methanol-soluble fraction of Millettia macrophylla (Fabaceae) stem bark endowed with estrogenic properties has adverse effects on the male reproductive system of Wistar rats,” Journal of Basic and Clinical Physiology and Pharmacology, 2014. View at Publisher · View at Google Scholar
  23. A. E. Wakeling and J. Bowler, “ICI 182,780, a new antioestrogen with clinical potential,” Journal of Steroid Biochemistry and Molecular Biology, vol. 43, no. 1–3, pp. 173–177, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Howell, CK. Osborne, C. Morris, and AE. Wakeling, “ICI 182,780 (Faslodex): development of a novel, “pure” antiestrogen,” Cancer, vol. 89, no. 4, pp. 817–825, 2000. View at Google Scholar
  25. A. E. Wakeling, M. Dukes, and J. Bowler, “A potent specific pure antiestrogen with clinical potential,” Cancer Research, vol. 51, no. 15, pp. 3867–3873, 1991. View at Google Scholar · View at Scopus
  26. R. Y. K. Chan, W. F. Chen, A. Dong, D. Guo, and M. S. Wong, “Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3691–3695, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Djiogue, D. Njamen, M. Halabalaki et al., “Estrogenic properties of naturally occurring prenylated isoflavones in U2OS human osteosarcoma cells: structure-activity relationships,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 120, no. 4-5, pp. 184–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Wakeling, “The future of new pure antiestrogens in clinical breast cancer,” Breast Cancer Research and Treatment, vol. 25, no. 1, pp. 1–9, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Morito, T. Hirose, J. Kinjo et al., “Interaction of phytoestrogens with estrogen receptors α and β,” Biological and Pharmaceutical Bulletin, vol. 24, no. 4, pp. 351–356, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. Umland, J. S. Cauffield, J. K. Kirk, and T. E. Thomason, “Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women,” Pharmacotherapy, vol. 20, no. 8, pp. 981–990, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Adlercreutz and W. Mazur, “Phyto-oestrogens and Western diseases,” Annals of Medicine, vol. 29, no. 2, pp. 95–120, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. L. W. Lissin and J. P. Cooke, “Phytoestrogens and cardiovascular health,” Journal of the American College of Cardiology, vol. 35, no. 6, pp. 1403–1410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Ranich, S. J. Bhathena, and M. T. Velasquez, “Protective effects of dietary phytoestrogens in chronic renal disease,” Journal of Renal Nutrition, vol. 11, no. 4, pp. 183–193, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Chandrareddy, O. Muneyyirci-Delale, S. I. McFarlane, and O. M. Murad, “Adverse effects of phytoestrogens on reproductive health: A report of three cases,” Complementary Therapies in Clinical Practice, vol. 14, no. 2, pp. 132–135, 2008. View at Publisher · View at Google Scholar · View at Scopus